GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dallah Healthcare Co (SAU:4004) » Definitions » Days Sales Outstanding

Dallah Healthcare Co (SAU:4004) Days Sales Outstanding : 83.20 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Dallah Healthcare Co Days Sales Outstanding?

Dallah Healthcare Co's average Accounts Receivable for the three months ended in Mar. 2024 was ﷼715 Mil. Dallah Healthcare Co's Revenue for the three months ended in Mar. 2024 was ﷼784 Mil. Hence, Dallah Healthcare Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 83.20.

The historical rank and industry rank for Dallah Healthcare Co's Days Sales Outstanding or its related term are showing as below:

SAU:4004' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.69   Med: 97.03   Max: 125.9
Current: 91.75

During the past 13 years, Dallah Healthcare Co's highest Days Sales Outstanding was 125.90. The lowest was 85.69. And the median was 97.03.

SAU:4004's Days Sales Outstanding is ranked worse than
84.06% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 45.94 vs SAU:4004: 91.75

Dallah Healthcare Co's Days Sales Outstanding declined from Mar. 2023 (92.80) to Mar. 2024 (83.20).


Dallah Healthcare Co Days Sales Outstanding Historical Data

The historical data trend for Dallah Healthcare Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dallah Healthcare Co Days Sales Outstanding Chart

Dallah Healthcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.92 125.90 104.48 95.52 86.73

Dallah Healthcare Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.80 105.30 95.72 86.48 83.20

Competitive Comparison of Dallah Healthcare Co's Days Sales Outstanding

For the Medical Care Facilities subindustry, Dallah Healthcare Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dallah Healthcare Co's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Dallah Healthcare Co's Days Sales Outstanding falls into.



Dallah Healthcare Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Dallah Healthcare Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (677.076 + 721.443) / 2 ) / 2942.898*365
=699.2595 / 2942.898*365
=86.73

Dallah Healthcare Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (721.443 + 708.287) / 2 ) / 784.056*365 / 4
=714.865 / 784.056*365 / 4
=83.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dallah Healthcare Co  (SAU:4004) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Dallah Healthcare Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Dallah Healthcare Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Dallah Healthcare Co (SAU:4004) Business Description

Traded in Other Exchanges
N/A
Address
1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Service/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.

Dallah Healthcare Co (SAU:4004) Headlines

No Headlines